— Know what they know.
Not Investment Advice

NNLX OTC

NanoLogix, Inc.
1W: +0.0% 1M: +0.0% 3M: -20.0% YTD: -20.0% 1Y: -20.0% 3Y: -20.0% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 53 · $9569 mcap · 46M float · 0.0011% daily turnover · Short 62% of daily vol

Balance Sheet Trends

Total Assets
$727K -18.4% ▼
5Y CAGR: +0.6%
Total Liabilities
$116K +5504.9% ▲
5Y CAGR: -19.5%
Shareholders Equity
$611K -31.2% ▼
5Y CAGR: +11.1%
Cash & Investments
$3K -94.7% ▼
5Y CAGR: -27.1%
Total Debt
$100K +0.0% ▲
5Y CAGR: +27.4%
Net Debt
$97K +252.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2009FY2010FY2011FY2012FY2013
— Assets —
Cash$89K$211K$115K$64K$3K
Short-Term Investments$8$0$0$0$0
Cash & ST Investments$89K$211K$115K$64K$3K
Net Receivables$0$12K$0$111K$118K
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$89K$224K$119K$180K$125K
Property, Plant & Equip.$222K$585K$497K$451K$382K
Goodwill & Intangibles$381K$338K$298K$258K$218K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$4K$10K$8K$2K$2K
Total Non-Current Assets$606K$933K$802K$710K$602K
Total Assets$695K$1M$921K$890K$727K
— Liabilities —
Accounts Payable$201K$32K$9K$2K$16K
Short-Term Debt$0$0$0$0$100K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$253K$32K$9K$2K$116K
Long-Term Debt$37K$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$37K$0$0$0$0
Total Liabilities$290K$32K$9K$2K$116K
— Equity —
Common Stock$10K$11K$12K$12K$13K
Retained Earnings-$19M-$22M-$24M-$26M-$27M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$405K$1M$912K$888K$611K
Total Liabilities & Equity$695K$1M$921K$890K$727K
— Key Metrics —
Total Debt$37K$0$0$0$100K
Net Debt-$52K-$211K-$115K-$64K$97K
Total Investments$8$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms